MR Spectroscopy and Spectroscopic Imaging of the Brain

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 711)

Abstract

Magnetic resonance spectroscopy (MRS) and the related technique of magnetic resonance spectroscopic imaging (MRSI) are widely used in both clinical and preclinical research for the non-invasive evaluation of brain metabolism. They are also used in medical practice, although their ultimate clinical value continues to be a source of discussion. This chapter reviews the general information content of brain spectra and commonly used protocols for both MRS and MRSI and also touches on data analysis methods and quantitation. The main focus is on proton MRS for application in humans, but many of the methods are also applicable to other nuclei and studies of animal models as well.

Key words

Brain magnetic resonance spectroscopy spectroscopic imaging spatial localization metabolites 

Notes

Acknowledgments

Supported in part by National Institutes of Health grant P41 RR015241.

References

  1. 1.
    Cady, E. B., Costello, A. M., Dawson, M. J., Delpy, D. T., Hope, P. L., Reynolds, E. O., Tofts, P. S., Wilkie, D. R. Non-invasive investigation of cerebral metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. Lancet 1983;1(8333):1059–1062.PubMedGoogle Scholar
  2. 2.
    Bottomley, P. A., Edelstein, W. A., Foster, T. H., Adams, W. A. In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: A window to metabolism? Proc Natl Acad Sci USA 1985;82(7):2148–2152.PubMedGoogle Scholar
  3. 3.
    Barker, P. B., Lin, D. D. In vivo proton MR spectroscopy of the human brain. Prog NMR Spect 2006;49:99–128.Google Scholar
  4. 4.
    Goldman, M., Johannesson, H., Axelsson, O., Karlsson, M. Hyperpolarization of 13C through order transfer from parahydrogen: A new contrast agent for MRI. Magn Reson Imaging 2005;23(2):153–157.PubMedGoogle Scholar
  5. 5.
    Barker, P. B., Gillard, J. H., van Zijl, P. C., Soher, B. J., Hanley, D. F., Agildere, A. M., Oppenheimer, S. M., Bryan, R. N. Acute stroke: Evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192(3):723–732.PubMedGoogle Scholar
  6. 6.
    Remy, C., Grand, S., Lai, E. S., Belle, V., Hoffmann, D., Berger, F., Esteve, F., Ziegler, A., Le Bas, J. F., Benabid, A. L., Decorps, M., Segebarth, C. M. 1H MRS of human brain abscesses in vivo and in vitro. Magn Reson Med 1995;34(4):508–514.PubMedGoogle Scholar
  7. 7.
    Lin, D. D., Crawford, T. O., Barker, P. B. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 2003;24(1):33–41.PubMedGoogle Scholar
  8. 8.
    Govindaraju, V., Young, K., Maudsley, A. A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000;13(3):129–153.PubMedGoogle Scholar
  9. 9.
    Frahm, J., Michaelis, T., Merboldt, K. D., Hanicke, W., Gyngell, M. L., Bruhn, H. On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed 1991;4(4):201–204.PubMedGoogle Scholar
  10. 10.
    Pouwels, P. J., Frahm, J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997;10(2):73–78.PubMedGoogle Scholar
  11. 11.
    Barker, P. B. N-acetyl aspartate – a neuronal marker? Ann Neurol 2001;49(4):423–424.PubMedGoogle Scholar
  12. 12.
    Simmons, M. L., Frondoza, C. G., Coyle, J. T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45(1):37–45.PubMedGoogle Scholar
  13. 13.
    Bhakoo, K. K., Pearce, D. In vitro expression of N-acetyl aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000;74(1):254–262.PubMedGoogle Scholar
  14. 14.
    Burlina, A. P., Ferrari, V., Facci, L., Skaper, S. D., Burlina, A. B. Mast cells contain large quantities of secretagogue-sensitive N- acetylaspartate. J Neurochem 1997;69(3):1314–1317.PubMedGoogle Scholar
  15. 15.
    Urenjak, J., Williams, S. R., Gadian, D. G., Noble, M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte- type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992;59(1):55–61.PubMedGoogle Scholar
  16. 16.
    Barker, P., Breiter, S., Soher, B., Chatham, J., Forder, J., Samphilipo, M., Magee, C., Anderson, J. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 1994;32:157–163.PubMedGoogle Scholar
  17. 17.
    Gill, S. S., Small, R. K., Thomas, D. G., Patel, P., Porteous, R., van Bruggen, N., Gadian, D. G., Kauppinen, R. A., Williams, S. R. Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2(5–6):196–200.PubMedGoogle Scholar
  18. 18.
    Gill, S. S., Thomas, D. G., Van, B. N., Gadian, D. G., Peden, C. J., Bell, J. D., Cox, I. J., Menon, D. K., Iles, R. A., Bryant, D. J. Proton MR spectroscopy of intracranial tumours: In vivo and in vitro studies. J Comput Assist Tomogr 1990;14(4):497–504.PubMedGoogle Scholar
  19. 19.
    Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., McDonald, W. I. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993;341(8845):630–631.PubMedGoogle Scholar
  20. 20.
    Brenner, R. E., Munro, P. M., Williams, S. C., Bell, J. D., Barker, G. J., Hawkins, C. P., Landon, D. N., McDonald, W. I. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29(6):737–745.PubMedGoogle Scholar
  21. 21.
    Kreis, R., Ross, B. D., Farrow, N. A., Ackerman, Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182(1):19–27.PubMedGoogle Scholar
  22. 22.
    Stoll, A. L., Renshaw, P. F., De Micheli, E., Wurtman, R., Pillay, S. S., Cohen, B. M. Choline ingestion increases the resonance of choline-containing compounds in human brain: An in vivo proton magnetic resonance study. Biol Psychiatry 1995;37(3):170–174.PubMedGoogle Scholar
  23. 23.
    Urenjak, J., Williams, S. R., Gadian, D. G., Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989.PubMedGoogle Scholar
  24. 24.
    Jacobs, M. A., Horska, A., van Zijl, P. C., Barker, P. B. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med 2001;46(4):699–705.PubMedGoogle Scholar
  25. 25.
    Penrice, J., Cady, E. B., Lorek, A., Wylezinska, M., Amess, P. N., Aldridge, R. F., Stewart, A., Wyatt, J. S., Reynolds, E. O. Proton magnetic resonance spectroscopy of the brain in normal preterm and term infants, and early changes after perinatal hypoxia-ischemia. Pediatr Res 1996;40(1):6–14.PubMedGoogle Scholar
  26. 26.
    Petroff, O. A., Graham, G. D., Blamire, A. M., al-Rayess, M., Rothman, D. L., Fayad, P. B., Brass, L. M., Shulman, R. G., Prichard, J. W. Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes. Neurology 1992;42(7):1349–1354.PubMedGoogle Scholar
  27. 27.
    Alger, J. R., Frank, J. A., Bizzi, A., Fulham, M. J., DeSouza, B. X., Duhaney, M. O., Inscoe, S. W., Black, J. L., van Zijl, P. C., Moonen, C. T. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177(3):633–641.PubMedGoogle Scholar
  28. 28.
    Mathews, P. M., Andermann, F., Silver, K., Karpati, G., Arnold, D. L. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43(12):2484–2490.PubMedGoogle Scholar
  29. 29.
    Brand, A., Richter-Landsberg, C., Leibfritz, D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15(3–5):289–298.PubMedGoogle Scholar
  30. 30.
    Flogel, U., Willker, W., Leibfritz, D. Regulation of intracellular pH in neuronal and glial tumour cells, studied by multinuclear NMR spectroscopy. NMR Biomed 1994;7(4):157–166.PubMedGoogle Scholar
  31. 31.
    Ross, B. D., Michaelis, T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191–247.PubMedGoogle Scholar
  32. 32.
    Shonk, T. K., Moats, R. A., Gifford, P., Michaelis, T., Mandigo, J. C., Izumi, J., Ross, B. D. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 1995;195(1):65–72.PubMedGoogle Scholar
  33. 33.
    Kruse, B., Hanefeld, F., Christen, H. J., Bruhn, H., Michaelis, T., Hanicke, W., Frahm, J. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 1993;241(2):68–74.PubMedGoogle Scholar
  34. 34.
    Magistretti, P. J., Pellerin, L., Rothman, D. L., Shulman, R. G. Energy on demand. Science 1999;283(5401):496–497.PubMedGoogle Scholar
  35. 35.
    Tkac, I., Andersen, P., Adriany, G., Merkle, H., Ugurbil, K., Gruetter, R. In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med 2001;46(3):451–456.PubMedGoogle Scholar
  36. 36.
    Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., Pelletier, D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005;128(Pt 5):1016–1025.PubMedGoogle Scholar
  37. 37.
    Kreis, R., Pfenninger, J., Herschkowitz, N., Boesch, C. In vivo proton magnetic resonance spectroscopy in a case of Reye’s syndrome. Intensive Care Med 1995;21(3):266–269.PubMedGoogle Scholar
  38. 38.
    van Zijl, P. C. M., Barker, P. B. Magnetic Resonance Spectroscopy and Spectroscopic Imaging for the Study of Brain Metabolism. Imaging Brain Structure and Function, Vol. 820. New York, NY: Annals of the New York Academy of Sciences; 1997, pp 75–96.Google Scholar
  39. 39.
    Rothman, D. L., Petroff, O. A., Behar, K. L., Mattson, R. H. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993;90(12):5662–5666.PubMedGoogle Scholar
  40. 40.
    Terpstra, M., Henry, P. G., Gruetter, R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003;50(1):19–23.PubMedGoogle Scholar
  41. 41.
    Pan, J. W., Telang, F. W., Lee, J. H., de Graaf, R. A., Rothman, D. L., Stein, D. T., Hetherington, H. P. Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 2001;79(3):539–544.PubMedGoogle Scholar
  42. 42.
    Seymour, K. J., Bluml, S., Sutherling, J., Sutherling, W., Ross, B. D. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma 1999;8(1):33–42.PubMedGoogle Scholar
  43. 43.
    Kreis, R., Pietz, J., Penzien, J., Herschkowitz, N., Boesch, C. Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy. J Magn Reson B 1995;107(3):242–251.PubMedGoogle Scholar
  44. 44.
    van der Knaap, M. S., Wevers, R. A., Struys, E. A., Verhoeven, N. M., Pouwels, P. J., Engelke, U. F., Feikema, W., Valk, J., Jakobs, C. Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 1999;46(6):925–928.PubMedGoogle Scholar
  45. 45.
    Cady, E. B., Lorek, A., Penrice, J., Reynolds, E. O., Iles, R. A., Burns, S. P., Coutts, G. A., Cowan, F. M. Detection of propan-1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med 1994;32(6):764–767.PubMedGoogle Scholar
  46. 46.
    Hanstock, C. C., Rothman, D. L., Shulman, R. G., Novotny, E. J., Jr., Petroff, O. A., Prichard, J. W. Measurement of ethanol in the human brain using NMR spectroscopy. J Stud Alcohol 1990;51(2):104–107.PubMedGoogle Scholar
  47. 47.
    Rose, S. E., Chalk, J. B., Galloway, G. J., Doddrell, D. M. Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Imaging 2000;18(1):95–98.PubMedGoogle Scholar
  48. 48.
    Vermathen, P., Capizzano, A. A., Maudsley, A. A. Administration and (1)H MRS detection of histidine in human brain: Application to in vivo pH measurement. Magn Reson Med 2000;43(5):665–675.PubMedGoogle Scholar
  49. 49.
    Rothman, D. L., Behar, K. L., Prichard, J. W., Petroff, O. A. Homocarnosine and the measurement of neuronal pH in patients with epilepsy. Magn Reson Med 1997;38(6):924–929.PubMedGoogle Scholar
  50. 50.
    Mori, S., Eleff, S. M., Pilatus, U., Mori, N., van Zijl, P. C. Proton NMR spectroscopy of solvent-saturable resonances: A new approach to study pH effects in situ. Magn Reson Med 1998;40(1):36–42.PubMedGoogle Scholar
  51. 51.
    Frahm, J. Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987;72(3):502–508.Google Scholar
  52. 52.
    van Zijl, P. C., Moonen, C. T., Alger, J. R., Cohen, J. S., Chesnick, S. A. High field localized proton spectroscopy in small volumes: Greatly improved localization and shimming using shielded strong gradients. Magn Reson Med 1989;10(2):256–265.PubMedGoogle Scholar
  53. 53.
    Duyn, J. H., Gillen, J., Sobering, G., van Zijl, P. C., Moonen, C. T. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188(1):277–282.PubMedGoogle Scholar
  54. 54.
    Ordidge, R. J. Random noise selective excitation pulses. Magn Reson Med 1987;5(1):93–98.PubMedGoogle Scholar
  55. 55.
    Moonen, C. T. W., Sobering, G., van Zijl, P. C. M., Gillen, J., von Kienlin, M., Bizzi, A. Proton spectroscopic imaging of human brain. J Magn Reson 1992;98(3):556–575.Google Scholar
  56. 56.
    Moonen, C. T., von Kienlin, M., van Zijl, P. C., Cohen, J., Gillen, J., Daly, P., Wolf, G. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989;2(5–6):201–208.PubMedGoogle Scholar
  57. 57.
    Tkac, I., Starcuk, Z., Choi, I. Y., Gruetter, R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999;41(4):649–656.PubMedGoogle Scholar
  58. 58.
    Collins, C. M., Liu, W., Schreiber, W., Yang, Q. X., Smith, M. B. Central brightening due to constructive interference with, without, and despite dielectric resonance. J Magn Reson Imaging 2005;21(2):192–196.PubMedGoogle Scholar
  59. 59.
    Slotboom, J., Mehlkopf, A. F., Bovee, W. M. M. J. A single-shot localization pulse sequence suited for coils with inhomogeneous RF fields using adiabatic slice-selective RF pulses. J Magn Reson 1991;95:396–404.Google Scholar
  60. 60.
    Garwood, M., DelaBarre, L. The return of the frequency sweep: Designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153(2):155–177.PubMedGoogle Scholar
  61. 61.
    Scheenen, T. W., Heerschap, A., Klomp, D. W. Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses. Magma 2008;21(1–2):95–101.PubMedGoogle Scholar
  62. 62.
    Scheenen, T. W., Klomp, D. W., Wijnen, J. P., Heerschap, A. Short echo time 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn Reson Med 2008;59(1):1–6.PubMedGoogle Scholar
  63. 63.
    Hwang, T. -L., Shaka, A. J. Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients. J Magn Reson Ser A 1995;112:275–279.Google Scholar
  64. 64.
    Levitt, M. H., Freeman, R. Compensation for pulse imperfections in NMR spin echo experiments. J Magn Reson 1981;43:65–80.Google Scholar
  65. 65.
    Mekle, R., Mlynarik, V., Gambarota, G., Hergt, M., Krueger, G., Gruetter, R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 2009;61(6):1279–1285.PubMedGoogle Scholar
  66. 66.
    Ordidge, R. J., Connelly, A., Lohman, J. A. B. Image-selected in vivo spectroscopy (ISIS) – a new technique for spatially selective NMR-spectroscopy. J Magn Reson 1986;66(2):283–294.Google Scholar
  67. 67.
    Ernst, R. R., Bodenhausen, G., Wokaun, A. Principles of Nuclear Magnetic Resonance in One and Two Dimensions. New York, NY: Oxford University Press; 1990, 640 p.Google Scholar
  68. 68.
    Golay, X., Gillen, J., van Zijl, P. C., Barker, P. B. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med 2002;47(2):384–387.PubMedGoogle Scholar
  69. 69.
    Pohmann, R., von Kienlin, M., Haase, A. Theoretical evaluation and comparison of fast chemical shift imaging methods. J Magn Reson 1997;129(2):145–160.PubMedGoogle Scholar
  70. 70.
    Duyn, J. H., Moonen, C. T. Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med 1993;30(4):409–414.PubMedGoogle Scholar
  71. 71.
    Martin, A. J., Liu, H., Hall, W. A., Truwit, C. L. Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. AJNR Am J Neuroradiol 2001;22(5):959–968.PubMedGoogle Scholar
  72. 72.
    Mansfield, P. Spatial mapping of chemical shift in NMR. Magn Reson Med 1984;1:370–386.PubMedGoogle Scholar
  73. 73.
    Posse, S., Tedeschi, G., Risinger, R., Ogg, R., Le Bihan, D. High speed 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995;33(1):34–40.PubMedGoogle Scholar
  74. 74.
    Posse, S., DeCarli, C., Le Bihan, D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology 1994;192(3):733–738.PubMedGoogle Scholar
  75. 75.
    Ebel, A., Soher, B. J., Maudsley, A. A. Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis. Magn Reson Med 2001;46(6):1072–1078.PubMedGoogle Scholar
  76. 76.
    Ebel, A., Maudsley, A. A., Weiner, M. W., Schuff, N. Achieving sufficient spectral bandwidth for volumetric 1H echo-planar spectroscopic imaging at 4 Tesla. Magn Reson Med 2005;54(3):697–701.PubMedGoogle Scholar
  77. 77.
    Pelletier, D., Nelson, S. J., Grenier, D., Lu, Y., Genain, C., Goodkin, D. E. 3-D echo planar (1)HMRS imaging in MS: Metabolite comparison from supratentorial vs. central brain. Magn Reson Imaging 2002;20(8):599–606.PubMedGoogle Scholar
  78. 78.
    Govindaraju, V., Gauger, G. E., Manley, G. T., Ebel, A., Meeker, M., Maudsley, A. A. Volumetric proton spectroscopic imaging of mild traumatic brain injury. AJNR Am J Neuroradiol 2004;25(5):730–737.PubMedGoogle Scholar
  79. 79.
    Adalsteinsson, E., Irarrazabal, P., Topp, S., Meyer, C., Macovski, A., Spielman, D. M. Volumetric spectroscopic imaging with spiral-based K-space trajectories. Magn Reson Med 1998;39(6):889–898.PubMedGoogle Scholar
  80. 80.
    Block, K. T., Frahm, J. Spiral imaging: A critical appraisal. J Magn Reson Imaging 2005;21(6):657–668.PubMedGoogle Scholar
  81. 81.
    Adalsteinsson, E., Star-Lack, J., Meyer, C. H., Spielman, D. M. Reduced spatial side lobes in chemical-shift imaging. Magn Reson Med 1999;42(2):314–323.PubMedGoogle Scholar
  82. 82.
    Sarkar, S., Heberlein, K., Hu, X. Truncation artifact reduction in spectroscopic imaging using a dual-density spiral K-space trajectory. Magn Reson Imaging 2002;20(10):743–757.PubMedGoogle Scholar
  83. 83.
    Kim, D. H., Adalsteinsson, E., Spielman, D. M. Spiral readout gradients for the reduction of motion artifacts in chemical shift imaging. Magn Reson Med 2004;51(3):458–463.PubMedGoogle Scholar
  84. 84.
    Adalsteinsson, E., Langer-Gould, A., Homer, R. J., Rao, A., Sullivan, E. V., Lima, C. A., Pfefferbaum, A., Atlas, S. W. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2003;24(10):1941–1945.PubMedGoogle Scholar
  85. 85.
    Pruessmann, K. P., Weiger, M., Scheidegger, M. B., Boesiger, P. SENSE: Sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952–962.PubMedGoogle Scholar
  86. 86.
    Sodickson, D. K., Manning, W. J. Simultaneous acquisition of spatial harmonics (SMASH): Fast imaging with radiofrequency coil arrays. Magn Reson Med 1997;38(4):591–603.PubMedGoogle Scholar
  87. 87.
    Jakob, P. M., Griswold, M. A., Edelman, R. R., Sodickson, D. K. AUTO-SMASH: A self-calibrating technique for SMASH imaging. Simultaneous acquisition of spatial harmonics. Magma 1998;7(1):42–54.PubMedGoogle Scholar
  88. 88.
    McKenzie, C. A., Yeh, E. N., Ohliger, M. A., Price, M. D., Sodickson, D. K. Self-calibrating parallel imaging with automatic coil sensitivity extraction. Magn Reson Med 2002;47(3):529–538.PubMedGoogle Scholar
  89. 89.
    Griswold, M. A., Jakob, P. M., Heidemann, R. M., Nittka, M., Jellus, V., Wang, J., Kiefer, B., Haase, A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47(6):1202–1210.PubMedGoogle Scholar
  90. 90.
    Dydak, U., Weiger, M., Pruessmann, K. P., Meier, D., Boesiger, P. Sensitivity-encoded spectroscopic imaging. Magn Reson Med 2001;46(4):713–722.PubMedGoogle Scholar
  91. 91.
    Tsai, S. Y., Otazo, R., Posse, S., Lin, Y. R., Chung, H. W., Wald, L. L., Wiggins, G. C., Lin, F. H. Accelerated proton echo planar spectroscopic imaging (PEPSI) using GRAPPA with a 32-channel phased-array coil. Magn Reson Med 2008;59(5):989–998.PubMedGoogle Scholar
  92. 92.
    Dydak, U., Pruessmann, K. P., Weiger, M., Tsao, J., Meier, D., Boesiger, P. Parallel spectroscopic imaging with spin-echo trains. Magn Reson Med 2003;50(1):196–200.PubMedGoogle Scholar
  93. 93.
    Lin, F. H., Tsai, S. Y., Otazo, R., Caprihan, A., Wald, L. L., Belliveau, J. W., Posse, S. Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain. Magn Reson Med 2007;57(2):249–257.PubMedGoogle Scholar
  94. 94.
    Smith, M. A., Gillen, J., McMahon, M. T., Barker, P. B., Golay, X. Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med 2005;54(3):691–696.PubMedGoogle Scholar
  95. 95.
    Dreher, W., Leibfritz, D. Detection of homonuclear decoupled in vivo proton NMR spectra using constant time chemical shift encoding: CT-PRESS. Magn Reson Imaging 1999;17(1):141–150.PubMedGoogle Scholar
  96. 96.
    Haase, A., Frahm, J., Hanicke, W., Matthei, D. 1H NMR chemical shift selective imaging. Phys Med Biol 1985;30(4):341–344.PubMedGoogle Scholar
  97. 97.
    Moonen, C. T. W., van Zijl, P. C. M. Highly efficient water suppression for in vivo proton NMR spectroscopy. J Magn Reson 1990;88:28–41.Google Scholar
  98. 98.
    Ogg, R. J. WET a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1–10.PubMedGoogle Scholar
  99. 99.
    Mescher, M., Merkle, H., Kirsch, J., Garwood, M., Gruetter, R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998;11(6):266–272.PubMedGoogle Scholar
  100. 100.
    Star-Lack, J., Nelson, S. J., Kurhanewicz, J., Huang, L. R., Vigneron, D. B. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997;38(2):311–321.PubMedGoogle Scholar
  101. 101.
    Spielman, D. M., Pauly, J. M., Macovski, A., Glover, G. H., Enzmann, D. R. Lipid-suppressed single- and multisection proton spectroscopic imaging of the human brain. J Magn Reson Imaging 1992;2(3):253–262.PubMedGoogle Scholar
  102. 102.
    Gu, M., Spielman, D. M. B1 and T1 insensitive water and lipid suppression using optimized multiple frequency-selective preparation pulses for whole-brain 1H spectroscopic imaging at 3T. Magn Reson Med 2009;61(2):462–466.PubMedGoogle Scholar
  103. 103.
    Zhu, H., Ouwerkerk, R., Barker, P. B. Dual band water and lipid suppression for MR spectroscopic imaging at 3 Tesla. Magn Reson Med 2009;(accepted for publication).Google Scholar
  104. 104.
    Kelley, D. A., Wald, L. L., Star-Lack, J. M. Lactate detection at 3T: Compensating J coupling effects with BASING. J Magn Reson Imaging 1999;9(5):732–737.PubMedGoogle Scholar
  105. 105.
    Raphael, C. In vivo NMR spectral parameter estimation: A comparison between time and frequency domain methods. Magn Reson Med 1991;18:358–370.Google Scholar
  106. 106.
    de Beer, R., van den Boogaart, A., van Ormondt, D., Pijnappel, W. W., den Hollander, J. A., Marien, A. J., Luyten, P. R. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 1992;5(4):171–178.PubMedGoogle Scholar
  107. 107.
    Provencher, S. W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30(6):672–679.PubMedGoogle Scholar
  108. 108.
    Henriksen, O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995;8(4):139–148.PubMedGoogle Scholar
  109. 109.
    Soher, B. J., van Zijl, P. C., Duyn, J. H., Barker, P. B. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996;35(3):356–363.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.The Kennedy Krieger InstituteBaltimoreUSA

Personalised recommendations